Yichang Central People's Hospital — Yichang, Hubei

Public research footprint of Yichang Central People's Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Obstructive Pulmonary Disease · Obesity · Idiopathic Pulmonary Fibrosis · Systemic Lupus Erythematosus

Recently updated registry entries

NCT07230119 — A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1) (Active Not Recruiting)
NCT07741448 — Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC (Recruiting)
NCT07168161 — BDB-001 Phase III Trial in ANCA-Associated Vasculitis (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Yichang Central People's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.